Evaluation the role of MicroRNAs in diagnosis and prognosis of acute myeloid leukemia

Hind Salih Muhammid; Alaa Jawad Hassan; Hussein Naji Abdulla

doi:10.53730/ijhs.v6nS8.9713

Authors

Hind Salih Muhammid
hindalhamdani2020@gmail.com
PhD student in University of Babylon, College of Sciences, Dept. of Biology
Alaa Jawad Hassan University of Babylon, College of Sciences, Dept. of Biology
Hussein Naji Abdulla University Of Babylon ,College Of Medicine, Al Hillah, Babil

Keywords:

acute myeloid leukemia (AML), MicroRNAs, biomarkers

Abstract

Acute myeloid leukemia (AML) is a clonal disorder of hematopoietic progenitor cells which are characterized by relevant heterogeneity in terms of phenotypic, genotypic, and clinical features. Among the genetic aberrations that control disease development there are microRNAs (miRNAs). The present study aimed to investigate the role of miRNAs in diagnosis and prognosis of AML and it was designed as cross sectional study in patients with acute myeloid leukemia and normal individuals as control group, we determined: RNA yield and quality; and quantification of miRNA-203, miRNA-143, and miRNA-495 expression by Quantitative Real-Time PCR (qPCR) in the serum of AML patients and control groups. The study was conducted in period between December 2020 and September 2021 at the University of Babylon, College of Science, department of biology. In this case-control study, blood samples were collected from 115 AML patients (38 male and 77 female) and their ages ranged between 18 and 66 years , then, 60 patients were selected based on the quantity and natural color of their samples (28 male and 32 female), in addition to the 30 samples from healthy apparently subjects as a control group (11 male and 19 female), and this group matched with the patients groups.

Downloads

Download data is not yet available.

References

Bain, B. J., and Béné , M. C. (2019). Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid leukaemia . Acta Haematol .Haematologica, 141(4):, 232-–244. https://doi.org/10.1159/000496097.

Boddu , P. C., and Zeidan , A. M. (2019). Myeloid disorders after autoimmune disease. Best Practice and Research. Clinical Haematology, 32(1):, 74-–88. https://doi.org/10.1016/j.beha.2019.02.002.

Bonnet, D., and Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine,, 3(7), 730–737. https://doi.org/10.1038/nm0797-730.

Caivano, A.; , La Rocca , F.; , Simeon , V.; , Girasole , M.; , Dinarelli , S.; , Laurenzana , I.; , De Stradis, A.; , De Luca , L., Trino , S. and , Traficante, A., et al., D’Arena, G., Mansueto, G., Villani, O., Pietrantuono, G., Laurenti, L., Del Vecchio, L., and Musto, P. (2017). MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies—A short report. Cellular Oncology, 40(1):, 97–103. https://doi.org/10.1007/s13402-016-0300-x.

Chen, L. et al, Hou, J., Ye, L., Chen, Y., Cui, J., Tian, W., Li, C., and Liu, L. (2014). MicroRNA-143 regulates adipogenesis by modulating the MAP2K5-ERK5 signaling. Scientific Reports, 4, 3819 (2014). https://doi.org/10.1038/srep03819.

Croce, C. M. , and Calin, G. A. (2005) . miRNAs, cancer, and stem cell division. Cell, 122(1), 6–7 (2005). https://doi.org/10.1016/j.cell.2005.06.036.

Dixon-McIver, A., East, P., Mein, C. A. , Cazier, J. B. , Molloy, G. , Chaplin, T. , Andrew Lister, T. A. , Young, B. D., and Debernardi, S. (2008) . Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoSPLOS ONE 2008, 3(5), e2141. [CrossRefhttps://doi.org/10.1371/journal.pone.0002141]

Engen, Caroline and Hellesoy, Monica and Grob, Tim and Lowenberg , Bob and , Valk , Peter and Gjertsen , and Bjørn . (2020). Sex disparity in acute myeloid leukemia ,Evidence from a study of FLT3-ITD mutated patients. 10.1101/2020.09.04.20188219 .

Estey , E. H. (2014). Acute myeloid leukemia: 2014 update on risk-stratification and management. American Journal of Hematology 2014;, 89(11):, 1063-–1081. https://doi.org/10.1002/ajh.23834.

Fernandez, N. , Cordiner , R. A. , Young , R. S. , Hug , N. , Macias, S. ,and Cáceres , J. F. (2017). Genetic variation and RNA structure regulate microRNA biogenesis. Nature Communications, 8:, 15114. https://doi.org/10.1038/ncomms15114.

Ferrara, F., and Schiffer, C. A. (2013). Acute myeloid leukaemia in adults,. Lancet, 381 (9865) :, 484–495. https://doi.org/10.1016/S0140-6736(12)61727-9

Gaibullaeva, N. N. (2021). The role of clinical examination early diagnosis of glaucoma. International Journal of Health & Medical Sciences, 4(3), 333-337. https://doi.org/10.31295/ijhms.v4n3.1745

Goldstone , A. H., Burnett , A. K., Wheatley , K., Smith , A. G., Hutchinson , R. M. and , Clark , R. E., and Medical Research Council Adult Leukemia Working Party. (2001). Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: The results of the United Kingdom Medical Research Council AML11 trial. Blood, 98(5): , 1302-–1311. https://doi.org/10.1182/blood.v98.5.1302.

Grimwade , D., Walker , H., Harrison , G., Oliver , F., Chatters , S., Harrison , C. J., Wheatley , K., Burnett , A. K. ,and Goldstone , A. H., & Medical Research Council Adult Leukemia Working Party. (2001). The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysisAnalysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood, 98(5): , 1312-–1320. https://doi.org/10.1182/blood.v98.5.1312.

Haferlach , T., Schoch , C., Löffler , H., Gassmann, W., Kern, W., Schnittger, S., Fonatsch, C., Ludwig, W. D., Wuchter, C., Schlegelberger, B., Staib, P., Reichle, A., Kubica, U., Eimermacher, H., Balleisen, L., Grüneisen, A., Haase, D., Aul, C., Karow, J., and Hiddemann, W. (2003). Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: Results of a multiparameter analysis from the German AML Cooperative Group studies. Journal of Clinical Oncology 2003;, 21 (2): , 256–265. https://doi.org/10.1200/JCO.2003.08.005.

Hartmann, L., and Metzeler, K. H. (2019). Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications. Genes , Chromosomes and Cancer., 58(12):, 828-–838. https://doi.org/10.1002/gcc.22756.

Jaiswal , S., Fontanillas , P., Flannick , J., et al, Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., Higgins, J. M., Moltchanov, V., Kuo, F. C., Kluk, M. J., Henderson, B., Kinnunen, L., Koistinen, H. A., Ladenvall, C., Getz, G., and Ebert, B. L. (2014). Age-related clonal hematopoiesis associated with adverse outcomes. New England Journal of Medicine 2014;, 371(26):, 2488-–2498. https://doi.org/10.1056/NEJMoa1408617.

Jongen-Lavrencic, M. , Sun, S. M. , Dijkstra, M. K., Valk, P. J. M. , and Löwenberg, B. (2008) . MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008, 111(10), 5078–5085. [CrossRefhttps://doi.org/10.1182/blood-2008-01-133355] , [PubMed: 18337557]

Krakowsky, R. H. E. et al., Wurm, A. A., Gerloff, D., Katzerke, C., Bräuer-Hartmann, D., Hartmann, J. U., Wilke, F., Thiede, C., Müller-Tidow, C., Niederwieser, D., and Behre, G. (2018) . miR-451a abrogates treatment resistance in FLT3-ITDpositive acute myeloid leukemia . Blood Cancer Journal, 8(3), 36 (2018). https://doi.org/10.1038/s41408-018-0070-y.

Kuriyama , K. , Tomonaga , M. , Kobayashi , T. , Takeuchi , J. , Ohshima , T. , Furusawa , S. , Saitoh , K. and , Ohno , R. et al, and Japan Adult Leukemia Study Group. (2001). Morphological diagnoses of the Japan Adult Leukemia Study Group acute myeloid leukemia protocols: Central review. International Journal of Hematology 2001;, 73 (1): , 93- –99. https://doi.org/10.1007/BF02981909 .

Li , Z., Lu, J., Sun, M., Mi , S., Zhang , H., Luo, R. T., Chen, P., Wang, Y., Yan, M., Qian , Z., Neilly, M. B., Jin , J., Zhang , Y., Bohlander, S. K., Zhang, D. E., Larson, R. A., Le Beau, M. M., Thirman, M. J., Golub, T. R., Rowley, J.D., and Chen, J. .J. (2008). Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proceedings of the National Academy of Sciences of the United S States of America, 105(40):, 15535-–15540. https://doi.org/10.1073/pnas.0808266105

Lin, X.; , Wang, Z.; , Wang, Y., and Feng, W. (2015) . Serum microRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia. International Journal of Clinical and Experimental Pathology, 8(11):, 14658–14666.

Lindsley , R. C., Mar , B. G., Mazzola , E., et al, Grauman, P. V., Shareef, S., Allen, S. L., Pigneux, A., Wetzler, M., Stuart, R. K., Erba, H. P., Damon, L. E., Powell, B. L., Lindeman, N., Steensma, D. P., Wadleigh, M., DeAngelo, D. J., Neuberg, D., Stone, R. M., and Ebert, B. L. (2015). Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;, 125(9):, 1367-–1376. https://doi.org/10.1182/blood-2014-11-610543.

Livak, K. J. ,and Schmittgen, T. D. (2001). "Analysis of relative gene expression data using real-time quantitative PCR and the 2- ΔΔCT Method.". Methods , 25(4):, 402-–408. https://doi.org/10.1006/meth.2001.1262.

Lowenberg , B. (2001). Managing therapy in older adult patients with acute myeloid leukemia. Seminars in Hematology, 38(3) Suppl. 6: , 10-–16. https://doi.org/10.1016/s0037-1963(01)90151-9.

Maki , K.; , Yamagata, T.; , SugitamSugita , F.; , Nakamura , Y.; , Sasaki, K., and Mitani, K. (2012) . Aberrant expression of miR9 indicates poor prognosis in acute myeloid leukaemia. British Journal of Haematology, 158(2):, 283–285. https://doi.org/10.1111/j.1365-2141.2012.09118.x.

McMullin , M. F. , and Mackenzie , G. (2001). Survival from AML in patient over 55 years of age in Northern Ireland: A discrete population . Hematology, 6(2): , 103-–110. https://doi.org/10.1080/10245332.2001.11746560.

Mi , S., Lu, J., Sun, M., et al., Li, Z., Zhang, H., Neilly, M. B., Wang, Y., Qian, Z., Jin, J., Zhang, Y., Bohlander, S. K., Le Beau, M. M., Larson, R. A., Golub, T. R., Rowley, J. D., and Chen, J. (2007). MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 104(50):, 19971–19976. https://doi.org/10.1073/pnas.0709313104

Naghmi Asif, N. , and Khalid Hassan, K. (2013). Acute Myeloid leukemia amongst Adults,. Journal of Islamabad Medical & Dental College (JIMDC) ;2013;, 2(4):, 58-–63.

Newell , L. F., and Cook , R. J. (2021). Advances in acute myeloid leukemia. BMJ 2021;, 375 :, n2026 . doi:https://doi.org/10.1136/bmj.n2026.

Pichiorri, F.; , De Luca , L. ,and Aqeilan , R. I. (2011). MicroRNAs: New players in multiple myeloma. Frontiers in Genetics, 2:, 22. https://doi.org/10.3389/fgene.2011.00022.

Schoch , C., Schnitt gerGer, S. , Klaus, M., Kern, W., Hiddemann, W., Haferlach, T. S., and Klaus M, et al .(2003) . AML with 11q23/MLL abnormalities as defi ned by the WHO classifi cation: Incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood, 102(7):, 2395- –2402. https://doi.org/10.1182/blood-2003-02-0434.

Senyuk, V.; , Zhang, Y. ; , Liu, Y., and et. al., Ming, M., Premanand, K., Zhou, L., Chen, P., Chen, J., Rowley, J. D., Nucifora, G., and Qian, Z., (2013) . Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America, 110(14):, 5594-–5599. https://doi.org/10.1073/pnas.1302645110.

Sonneveld , P., Burnett , A. , Vossebeld , P., Ben-Am, M., Rosenkranz, G., Pfister, C., Verhoef, G., Dekker, A., Ossenkoppele, G., Ferrant, C., Yin, L., Gratwohl, A., Kovacsovics, T., Vellenga, E., Capdeville, R., and Löwenberg, B. (2000). Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. Hematology Journal, 1(6): , 411-–421. https://doi.org/10.1038/sj.thj.6200050.

Sorror , M. L., Storb , R. F., Sandmaier , B. M., et al, Maziarz, R. T., Pulsipher, M. A., Maris, M. B., Bhatia, S., Ostronoff, F., Deeg, H. J., Syrjala, K. L., Estey, E., Maloney, D. G., Appelbaum, F. R., Martin, P. J., and Storer, B. E. (2014). Comorbidity-age index: A clinical measure of biologic age before allogeneic hematopoietic cell transplantation. Journal of Clinical Oncology 2014;, 32(29):, 3249-–3256. https://doi.org/10.1200/JCO.2013.53.8157.

Sritana , N., and Auewarakul , C. U. (2008) . KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: 2 Novel mutations and selective occurrence in leukemia subtypes and age groups . Experimental and Molecular Pathology, 85(3):, 227- –231. https://doi.org/10.1016/j.yexmp.2008.09.004.

Suresh Attili, S.1, K.C. Lakshmiah, K. C.1, M. Madhumati, M.2, Kamal S. Saini, K. S.1, G. Anupama, G.1, Monika Lamba Saini, M. , and Lamba T.P.T. P. (2006) . Sahoo1 Simultaneous occurrence of multiple myeloma and acute myeloid leukemia ,. Turkish Journal of Hematology 2006;, 23:, 209-–211 .

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

Svoronos, A. A. , Engelman , D. M. ,and Slack, F. J. (2016). Oncomir or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Research, 76(13):, 3666–3670. https://doi.org/10.1158/0008-5472.CAN-16-0359.

Vitsios , D. M.; , Davis , M. P.; , van Dongen , S. ,and Enright , A. J. (2017) . Large-scale analysis of microRNA expression, epi-transcriptomic features and biogenesis. Nucleic Acids Research, 45(3):, 1079–1090. https://doi.org/10.1093/nar/gkw1031

Wallace, J. A. ,and O’Connell , R. M. (2017). MicroRNAs and acute myeloid leukemia: Therapeutic implications and emerging concepts. Blood., 130(11):, 1290–1301. https://doi.org/10.1182/blood-2016-10-697698.

Wang , X., Song , X., and Yan , X. (2019). Effect of RNA splicing machinery gene mutations on prognosis of patients with MDS: A meta-analysis. Medicine (Baltimore). 2019;, 98(21):, e15743. https://doi.org/10.1097/MD.0000000000015743.

Wang , Y., Li, Z., He, C., et al., Wang, D., Yuan, X., Chen, J., and Jin, J. (2010). MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells, Molecules, and Diseases , 44(3):, 191–197. https://doi.org/10.1016/j.bcmd.2009.12.010

Wang, Y.; , Li, Z.; , He, C.; , Wang, D.; , Yuan, X.; , Chen, J.; , and Jin, J. (2010) . MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells , Molecules and Diseases 2010, 44(3), 191–197. [CrossRefhttps://doi.org/10.1016/j.bcmd.2009.12.010] , [PubMed: 20110180]

Zhang, B., Pan, X., Cobb, G. P. , and Anderson, T. A. (2007) . microRNAs as oncogenes and tumor suppressors. Developmental Biology, 302(1), 1–12 (2007). https://doi.org/10.1016/j.ydbio.2006.08.028.

Zhi, F. , Cao, X., Xie, X. , Wang, B. , Dong, W., Gu, W. , Ling, Y., Wang, R. , Yang, Y. , and Liu, Y. (2013) . Identification of circulating microRNAs as potential biomarkers for detecting acute Myeloid leukemia. PLOS ONE 2013, 8(2), e56718. [CrossRefhttps://doi.org/10.1371/journal.pone.0056718]